Actuate Therapeutics, Inc. Common stock (ACTU) is a publicly traded Healthcare sector company. As of October 29, 2026, ACTU trades at $0.40 with a market cap of $9.59M and a P/E ratio of -0.82. ACTU moved +0.23% today. Year to date, ACTU is -93.64%; over the trailing twelve months it is -94.35%. Its 52-week range spans $0.35 to $11.99. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces ACTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ACTU shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.40 |
| Market Cap | $9.59M |
| P/E Ratio | -0.82 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.99 |
| 52-Week Low | $0.35 |
| Volume | 456.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-22.23M |
| Gross Margin | 0.00% |
2 analysts cover ACTU: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.